Clinical Trial Update: Addition of Raltegravir to Established Antiretroviral Suppressive Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the addition of raltegravir to established antiretroviral suppressive therapy in people with HIV was terminated, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: University of Miami | Conditions: HIV | Phase 4 | Status: TERMINATED | Results posted: 2016-12-23